A FTSE 100 dividend growth stock that I’d buy today and hold for the next 20 years

Royston Wild discusses a FTSE 100 (INDEXFTSE: UKX) dividend share he’d buy and hold for at least a couple of decades.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

My Foolish colleague Ian Pierce could be found lauding the investment case for Experian (LSE: EXPN) at the start of last month.

He could see the business extending the stunning near-25% share price increase it had punched in the six months to September, and so it came to pass, the FTSE 100 consumer credit reporting agency hitting fresh record peaks just shy of £20 per share in recent days.

Global Goliath

I’m not surprised at all. Indeed, I’ve been a big fan of Experian for a long, long time now, celebrating its rising might in the US and the brilliant long-term profits opportunities created by its push into Latin America and Asia Pacific.

And my enthusiasm, like that of the broader market, was reinforced by latest trading numbers released in July. Group revenues boomed 10% at constant exchange rates in the six months to June, the firm said, with sales on a comparable basis in the US gaining momentum in the first half having leapt 13% in the period.

Experian is benefiting from the strong economic conditions on the other side of the Atlantic, something which the credit scorers are exploiting with a steady stream of new product introductions.

Looking away from North America, strong uptake of its products in its Europe, Middle East, Africa and Asia Pacific regions helped aggregated turnover at stable exchange rates boom 11%. Sales growth in Latin America was slower at 4%, but this was far from a shameful performance given the current economic difficulties in the regional powerhouse of Brazil.

I’m particularly excited by Experian’s prospects in developing markets. As leaping personal wealth levels drive demand for credit, demand for the firm’s services is only likely to jump higher and higher.

Booming profits AND dividends

In the more immediate term, things certainly look pretty rosy for Experian. City analysts are forecasting a 3% profits rise in the year to March 2019. They are predicting that the bottom line will leap 11% in the following year.

And this bright outlook leads the number crunchers to expect the data darling to keep its progressive dividend programme in business. Last year’s 44.75 US cents per share payout is anticipated to advance to 45.9 cents in the current year. Next year’s estimated profits jump is expected to propel the dividend to 49.8 cents.

Subsequent yields of 1.8% and 2% may not make Experian the most generous income stock on the market. Still, the Footsie company’s dividend projections appear on much safer ground that some of the index’s bigger-yielding beasts. This isn’t just on account of its chubby dividend cover of 2.2 times through to the end of next year either.

Experian doesn’t come cheap thanks to its forward P/E ratio of 25.4 times. I would consider such a high valuation to be a fair rating given the likelihood of strong and sustained profits (and dividend) expansion through the next couple of decades.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has recommended Experian. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young Caucasian man making doubtful face at camera
Investing Articles

Surprise! This monopoly stock has taken over my Stocks and Shares ISA (again)

Our writer has a (nice) dilemma in his Stocks and Shares ISA portfolio after one incredible growth stock rocketed higher…

Read more »

Investing Articles

10.5% yield – but could the abrdn share price get even cheaper?

Christopher Ruane sees some things to like about the current abrdn share price. But will that be enough to overcome…

Read more »

Investing Articles

£9,000 to invest? These 3 high-yield shares could deliver a £657 annual passive income

The high yields on these dividend shares sail sit well above the FTSE 100 average of 3.6%. Here's why I…

Read more »

Surprised Black girl holding teddy bear toy on Christmas
Investing Articles

I’ve got £2k and I’m on the hunt for cheap shares to buy in December

Harvey Jones finally has some cash in his trading account and is hunting for cheap shares to buy next month.…

Read more »

Investing Articles

Down 25% with a 4.32% yield and P/E of 8.6! Is this my best second income stock or worst?

Harvey Jones bought GSK shares hoping to bag a solid second income stream while nailing down steady share price growth…

Read more »

Investing Articles

Here’s how the Legal & General dividend yield could ultimately hit 15%!

The Legal & General dividend yield is already among the best of any FTSE 100 share. Christopher Ruane explores some…

Read more »

Investing Articles

Is December a good time for me to buy UK shares?

This writer is weighing up which shares to buy for his portfolio next month, and one household name from the…

Read more »

Investing Articles

Is it time to dump my Lloyds shares and never look back?

Harvey Jones was chuffed with his Lloyds shares but recent events have made him rethink his entire decision to go…

Read more »